Oxford Covid-19 Vaccine
- All
- News
- Videos
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
- Thursday May 16, 2024
- World News | Indo-Asian News Service
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
- www.ndtv.com
-
Indian Medical Experts Support Call For Covishield Vaccine Safety Review
- Monday February 6, 2023
- India News | Press Trust of India
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of the Oxford/AstraZeneca's COVID-19 vaccine, administered in India as Covishield.
- www.ndtv.com
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
- Tuesday February 15, 2022
- World News | Reuters
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
- www.ndtv.com
-
Oxford Economics Revises India's 2022 GDP Growth Forecast To 7.9%
- Tuesday January 11, 2022
- Business | Reported by Himanshu Shekhar Mishra, Edited by Prashun Talukdar
Global forecasting firm Oxford Economics on Tuesday revised India's GDP (gross domestic product) growth forecast to 7.9 per cent from earlier 7.8 per cent for the current financial year 2021-22 (FY22), citing more durable recovery and higher Covid-19 vaccination rates.
- www.ndtv.com/business
-
Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
- Thursday December 23, 2021
- India News | Asian News International
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
- www.ndtv.com
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
- Thursday December 23, 2021
- World News | Reuters
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
- www.ndtv.com
-
Serum Institute Pledges $66 Million To Oxford University For Research
- Wednesday December 15, 2021
- World News | Reuters
Vaccine maker Serum Institute of India (SII) has pledged 50 million pounds ($66.2 million) to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot.
- www.ndtv.com
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
- Monday December 13, 2021
- World News | Reuters
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
- www.ndtv.com
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
- Monday December 6, 2021
- World News | Press Trust of India
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
- www.ndtv.com
-
Does Omicron Defeat Vaccines? No Sign Of That Yet, Says Oxford
- Wednesday December 1, 2021
- World News | Suzi Ring, Bloomberg
There's no evidence existing vaccines won't provide some protection against the omicron variant, the University of Oxford said as scientists scramble to assess the new Covid-19 mutation.
- www.ndtv.com
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
- Tuesday October 26, 2021
- World News | Press Trust of India
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
- www.ndtv.com
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
- Friday August 27, 2021
- World News | Press Trust of India
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
- www.ndtv.com
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
- Wednesday August 25, 2021
- World News | Reuters
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
- www.ndtv.com
-
Pfizer Jab Effectiveness "Declines Faster" Than AstraZeneca: Oxford Study
- Thursday August 19, 2021
- World News | Agence France-Presse
The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.
- www.ndtv.com
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
- Thursday August 12, 2021
- World News | Grace Gitau, Bloomberg
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
- www.ndtv.com
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
- Thursday May 16, 2024
- World News | Indo-Asian News Service
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
- www.ndtv.com
-
Indian Medical Experts Support Call For Covishield Vaccine Safety Review
- Monday February 6, 2023
- India News | Press Trust of India
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of the Oxford/AstraZeneca's COVID-19 vaccine, administered in India as Covishield.
- www.ndtv.com
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
- Tuesday February 15, 2022
- World News | Reuters
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
- www.ndtv.com
-
Oxford Economics Revises India's 2022 GDP Growth Forecast To 7.9%
- Tuesday January 11, 2022
- Business | Reported by Himanshu Shekhar Mishra, Edited by Prashun Talukdar
Global forecasting firm Oxford Economics on Tuesday revised India's GDP (gross domestic product) growth forecast to 7.9 per cent from earlier 7.8 per cent for the current financial year 2021-22 (FY22), citing more durable recovery and higher Covid-19 vaccination rates.
- www.ndtv.com/business
-
Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
- Thursday December 23, 2021
- India News | Asian News International
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
- www.ndtv.com
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
- Thursday December 23, 2021
- World News | Reuters
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
- www.ndtv.com
-
Serum Institute Pledges $66 Million To Oxford University For Research
- Wednesday December 15, 2021
- World News | Reuters
Vaccine maker Serum Institute of India (SII) has pledged 50 million pounds ($66.2 million) to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot.
- www.ndtv.com
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
- Monday December 13, 2021
- World News | Reuters
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
- www.ndtv.com
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
- Monday December 6, 2021
- World News | Press Trust of India
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
- www.ndtv.com
-
Does Omicron Defeat Vaccines? No Sign Of That Yet, Says Oxford
- Wednesday December 1, 2021
- World News | Suzi Ring, Bloomberg
There's no evidence existing vaccines won't provide some protection against the omicron variant, the University of Oxford said as scientists scramble to assess the new Covid-19 mutation.
- www.ndtv.com
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
- Tuesday October 26, 2021
- World News | Press Trust of India
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
- www.ndtv.com
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
- Friday August 27, 2021
- World News | Press Trust of India
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
- www.ndtv.com
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
- Wednesday August 25, 2021
- World News | Reuters
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
- www.ndtv.com
-
Pfizer Jab Effectiveness "Declines Faster" Than AstraZeneca: Oxford Study
- Thursday August 19, 2021
- World News | Agence France-Presse
The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.
- www.ndtv.com
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
- Thursday August 12, 2021
- World News | Grace Gitau, Bloomberg
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
- www.ndtv.com